Literature DB >> 18357343

The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children.

Calman A MacLennan1, Esther N Gondwe, Chisomo L Msefula, Robert A Kingsley, Nicholas R Thomson, Sarah A White, Margaret Goodall, Derek J Pickard, Stephen M Graham, Gordon Dougan, C Anthony Hart, Malcolm E Molyneux, Mark T Drayson.   

Abstract

Nontyphoidal strains of Salmonella (NTS) are a common cause of bacteremia among African children. Cell-mediated immune responses control intracellular infection, but they do not protect against extracellular growth of NTS in the blood. We investigated whether antibody protects against NTS bacteremia in Malawian children, because we found this condition mainly occurs before 2 years of age, with relative sparing of infants younger than 4 months old. Sera from all healthy Malawian children tested aged more than 16 months contained anti-Salmonella antibody and successfully killed NTS. Killing was mediated by complement membrane attack complex and not augmented in the presence of blood leukocytes. Sera from most healthy children less than 16 months old lacked NTS-specific antibody, and sera lacking antibody did not kill NTS despite normal complement function. Addition of Salmonella-specific antibody, but not mannose-binding lectin, enabled NTS killing. All NTS strains tested had long-chain lipopolysaccharide and the rck gene, features that resist direct complement-mediated killing. Disruption of lipopolysaccharide biosynthesis enabled killing of NTS by serum lacking Salmonella-specific antibody. We conclude that Salmonella-specific antibody that overcomes the complement resistance of NTS develops by 2 years of life in Malawian children. This finding and the age-incidence of NTS bacteremia suggest that antibody protects against NTS bacteremia and support the development of vaccines against NTS that induce protective antibody.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18357343      PMCID: PMC2268878          DOI: 10.1172/JCI33998

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Nontyphoidal Salmonella infections of children in tropical Africa.

Authors:  S M Graham; E M Molyneux; A L Walsh; J S Cheesbrough; M E Molyneux; C A Hart
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

2.  Biosynthesis of bacterial lipopolysaccharide. I. Enzymatic incorporation of galactose in a mutant strain of Salmonella.

Authors:  M J OSBORN; S M ROSEN; L ROTHFIELD; B L HORECKER
Journal:  Proc Natl Acad Sci U S A       Date:  1962-10-15       Impact factor: 11.205

3.  The Salmonella typhimurium virulence plasmid complement resistance gene rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and ail.

Authors:  E J Heffernan; J Harwood; J Fierer; D Guiney
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

4.  Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.

Authors:  Calman MacLennan; Claire Fieschi; David A Lammas; Capucine Picard; Susan E Dorman; Ozden Sanal; Jenny M MacLennan; Steven M Holland; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

5.  Intravenous immunoglobulin in the treatment of Salmonella typhimurium infections in preterm neonates.

Authors:  A S Gökalp; H B Toksoy; S Türkay; M Z Bakici; R Kaya
Journal:  Clin Pediatr (Phila)       Date:  1994-06       Impact factor: 1.168

6.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

Authors:  P I Fields; R V Swanson; C G Haidaris; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.

Authors:  K A Joiner; A B Tartanian; C H Hammer; J E Schweinle
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

8.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

9.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  117 in total

1.  Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1.

Authors:  Ceri Evans; Katharine Orf; Erzsebet Horvath; Michael Levin; Josu De La Fuente; Subarna Chakravorty; Aubrey J Cunnington
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

2.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

Review 3.  A dynamic view of the spread and intracellular distribution of Salmonella enterica.

Authors:  Pietro Mastroeni; Andrew Grant; Olivier Restif; Duncan Maskell
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

4.  Comparing the roles of antibodies to nontyphoidal Salmonella enterica in high- and low-income countries and implications for vaccine development.

Authors:  Calman A MacLennan; Sharon M Tennant
Journal:  Clin Vaccine Immunol       Date:  2013-07-31

Review 5.  Vaccination against Salmonella Infection: the Mucosal Way.

Authors:  Rémi Gayet; Gilles Bioley; Nicolas Rochereau; Stéphane Paul; Blaise Corthésy
Journal:  Microbiol Mol Biol Rev       Date:  2017-06-14       Impact factor: 11.056

Review 6.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 7.  Antimicrobial resistance and management of invasive Salmonella disease.

Authors:  Samuel Kariuki; Melita A Gordon; Nicholas Feasey; Christopher M Parry
Journal:  Vaccine       Date:  2015-04-23       Impact factor: 3.641

8.  Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype.

Authors:  Robert A Kingsley; Chisomo L Msefula; Nicholas R Thomson; Samuel Kariuki; Kathryn E Holt; Melita A Gordon; David Harris; Louise Clarke; Sally Whitehead; Vartul Sangal; Kevin Marsh; Mark Achtman; Malcolm E Molyneux; Martin Cormican; Julian Parkhill; Calman A MacLennan; Robert S Heyderman; Gordon Dougan
Journal:  Genome Res       Date:  2009-11-09       Impact factor: 9.043

9.  Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.

Authors:  Jessica R Hitchcock; Charlotte N Cook; Saeeda Bobat; Ewan A Ross; Adriana Flores-Langarica; Kate L Lowe; Mahmood Khan; C Coral Dominguez-Medina; Sian Lax; Manuela Carvalho-Gaspar; Stefan Hubscher; G Ed Rainger; Mark Cobbold; Christopher D Buckley; Tim J Mitchell; Andrea Mitchell; Nick D Jones; N Van Rooijen; Daniel Kirchhofer; Ian R Henderson; David H Adams; Steve P Watson; Adam F Cunningham
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

10.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.